XBody Go USA, XBody Pro USA
by Xbody Hungary Kft. 2 variants
510(k) K242926
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK242926 | Date30 May 2025 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- NGX
- Device Class
- Class II
- Regulation
- 21 CFR Part 890.5850
- Advisory Committee
- Physical Medicine
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
The XBody Go USA and XBody Pro USA are machines with electronic muscle stimulation based on EMS technology. They are specifically designed as an addition to other sports and for training muscles, and must be used only for healthy muscles.
These devices are classified as Stimulator, Muscle, Powered, For Muscle Conditioning (product code NGX), Class II - Special Controls. They were cleared by the FDA under 510(k) submission K242926 on May 30, 2025, following a traditional review process. The manufacturer is Xbody Hungary Kft., located in Budapest, Hungary.
Other devices from Xbody Hungary Kft.
Questions
AI-generated answers, 24 Sep 2026
What is the XBody Go USA and XBody Pro USA used for?
These devices are powered muscle stimulators designed as an addition to sports training for conditioning healthy muscles, using EMS technology to stimulate muscle activity.
How are the XBody Go USA and XBody Pro USA supplied and what is their intended use?
They are supplied as standalone machines for muscle conditioning and must be used only on healthy muscles as an adjunct to sports and training activities, not for medical treatment or rehabilitation.
What regulatory pathway was used for the XBody Go USA and XBody Pro USA?
The devices were cleared by the FDA through a traditional 510(k) submission (K242926) on May 30, 2025, based on substantial equivalence to a predicate device under product code NGX for powered muscle stimulators.